A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children

Lancet

Volumn 360, Issue 9344, 2002, Pages 1468-1475

  Hobbs, Maurine R ^a   Udhayakumar, Venkatachalam ^b   Levesque, Marc C ^c   Booth, Jennifer ^a   Roberts, Jacquelin M ^b   Tkachuk, Ariana N ^a   Pole, Ann ^a   Coon, Hilary ^a   Kariuki, Simon ^b   Nahlen, Bernard L ^b,d   Mwaikambo, Esther D ^e   Lal, Altaf L ^b   Granger, Donald L ^a   Anstey, Nicholas M ^f   Weinberg, J Brice ^c,g  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e HUBERT KAIRUKI MEMORIAL UNIVERSITY   (Tanzania)

^f FLINDERS UNIVERSITY   (Australia)

^g DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANEMIA; ARTICLE; BLOOD LEVEL; BRAIN MALARIA; CHILD; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENOTYPE; HUMAN; INFANT; KENYA; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALE; PARASITEMIA; PRIORITY JOURNAL; PROMOTER REGION; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; TANZANIA; URINE LEVEL;

EID: 0037048924     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11474-7     Document Type: Article

References (35)

1. Anon. World malaria situation in 1993. Wkly Epidemiol Rec 1996; 71: 17-22.
2. Marsh K., Forster D., Waruiru C., et al. Indicators of life-threatening malaria in African children. N Engl J Med. 332:1995;1399-1404.
3. Snow R.W., Omumbo J.A., Lowe B., et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet. 349:1997;1650-1654.
4. Akanmori B.D., Kurtzhals J.A., Goka B.Q., et al. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur Cytokine Netw. 11:2000;113-118.
5. Rockett K.A., Awburn M.M., Cowden W.B., Clark I.A. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun. 59:1991;3280-3283.
6. Seguin M.C., Klotz F.W., Schneider I., et al. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J Exp Med. 180:1994;353-358.
7. de Vera M.E., Shapiro R.A., Nussler A.K., et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA. 93:1996;1054-1059.
8. Levesque M.C., Hobbs M.R., Anstey N.M., et al. A review of polymorphisms in the human gene for inducible nitric oxide synthase (NOS2) in patients with malaria. Sepsis. 4:2001;217-231.
9. Kun J.F., Mordmuller B., Lell B., Lehman L.G., Luckner D., Kremsner P.G. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet. 351:1998;265-266.
10. Burgner D., Xu W., Rockett K., et al. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet. 352:1998;1193-1194.
11. Levesque M.C., Hobbs M.R., Anstey N.M., et al. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J Infect Dis. 180:1999;1994-2002.
12. Anstey N.M., Weinberg J.B., Hassanali M.Y., et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med. 184:1996;557-567.
13. Anstey N.M., Tissot Dupont H., Hahn C.G., et al. Seroepidemiology of Rickettsia typhi, spotted fever group rickettsiae, and Coxiella burnetti infection in pregnant women from urban Tanzania. Am J Trop Med Hyg. 57:1997;187-189.
14. Bloland P.B., Ruebush T.K., McCormick J.B., et al. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission, 1: description of study site, general methodology, and study population. Am J Trop Med Hyg. 60:1999;635-640.
15. Zhang L., Cui X., Schmitt K., Hubert R., Navidi W., Arnheim N. Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci USA. 89:1992;5847-5851.
16. Rust S., Funke H., Assmann G. Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res. 21:1993;3623-3629.
17. Xu W., Liu L., Emson P.C., Harrington C.R., Charles I.G. Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. Gene. 204:1997;165-170.
18. Morahan G., Boutlis C.S., Huang D., et al. A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immunity. 3:2002;414-418.
19. Aidoo M., Terlouw D.J., Kolczak M., et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet. 359:2002;1311-1312.
20. Dausset J., Cann H., Cohen D., Lathrop M., Lalouel J.M., White R. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics. 6:1990;575-577.
21. Anstey N.M., Weinberg J.B., Granger D.L. Nitric oxide in malaria. Fang F., Nitric oxide and infection. 1999;311-341 Plenum Publishing Corporation, New York.
22. Perkins D.J., Kremsner P.G., Schmid D., Misukonis M.A., Kelly M.A., Weinberg J.B. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy Gabonese children with prior mild or severe malaria. Infect Immun. 67:1999;4977-4981.
23. Kun J.F., Mordmuller B., Perkins D.J., et al. Nitric oxide synthase 2 (Lambarene) (-954 G→C), increased nitric oxide production, and protection against malaria. J Infect Dis. 184:2001;330-336.
24. Pombo D.J., Lawrence G., Hirunpetcharat C., et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet. 360:2002;610-617.
25. Alley E.W., Murphy W.J., Russell S.W. A classical enhancer element responsive to both lipopolysaccharide and interferon-gamma augments induction of the iNOS gene in mouse macrophages. Gene. 158:1995;247-251.
26. Heinemeyer T., Wingender E., Reuter I., et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26:1998;362-367.
27. Pance A., Chantome A., Reveneau S., Bentrari F., Jeannin J.F. A repressor in the proximal human inducible nitric oxide synthase promoter modulates transcriptional activation. Faseb J. 16:2002;631-633.
28. Hill A.V., Allsopp C.E., Kwiatkowski D., et al. Common west African HLA antigens are associated with protection from severe malaria. Nature. 352:1991;595-600.
29. Ohashi J., Naka I., Patarapotikul J., Hananantachai H., Looareesuwan S., Tokunaga K. Significant association of longer forms of CCTTT microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand. J Infect Dis. 186:2002;578-581.
30. Clark I., Awburn M. Migration inhibitory factor in the cerebral and systemic endothelium in sepsis and malaria. Crit Care Med. 30:(suppl. 5):2002;S263-267.
31. De Caterina R., Libby P., Peng H.B., et al. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 96:1995;60-68.
32. Turner G. Cerebral malaria. Brain Pathol. 7:1997;569-582.
33. Florquin S., Amraoui Z., Dubois C., Decuyper J., Yoldman M. The protective role of endogenously synthesized nitric oxide in staphylococeal enterotoxin B-induced shock in mice. J Exp Med. 180:1994;1153-1158.
34. Grau G.E., Taylor T.E., Molyneux M.E., et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 320:1989;1586-1591.
35. Engwerda C.R., Mynott T.L., Sawhney S., De Souza J.B., Bickle Q.D., Kaye P.M. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med. 195:2002;1371-1377.